Atara Biotherapeutics Inc (NAS:ATRA)
$ 0.605 0.0486 (8.73%) Market Cap: 72.85 Mil Enterprise Value: 76.99 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 35/100

Atara Biotherapeutics Inc at Goldman Sachs Global Healthcare Conference Transcript

Jun 13, 2019 / 05:00PM GMT
Release Date Price: $22.05 (+0.68%)
Maryana Ilya Breitman
Goldman Sachs Group Inc., Research Division - Research Analyst

Good morning. It is our pleasure to welcome Atara team. My name is Maryana Breitman, I'm an analyst here at Goldman Sachs. And from Atara, we have AJ Joshi, Chief Medical Officer. I have Utpal Koppikar, Chief Financial Officer; and Joe Newell, Chief Tech Op Officer. Thank you. Welcome.

Utpal Koppikar
Atara Biotherapeutics, Inc. - CFO

Thank you.

Manher Joshi
Atara Biotherapeutics, Inc. - Chief Medical Officer

Thank you.

Joseph Newell
Atara Biotherapeutics, Inc. - Executive VP & Chief Technical Operations Officer

Thank you.

Questions & Answers

Maryana Ilya Breitman
Goldman Sachs Group Inc., Research Division - Research Analyst

Let's recap a little. There's been a lot of changes at Atara. And we just learned that there's going to be major management changes. Could you talk a little bit about the process how that change is

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot